Matthew Yglesias @mattyglesias
I don’t really understand the putative Covid vaccine IP issue. In a typical “poor countries vs pharma” situation the medicine is not actually scarce, just expensive due to patent monopoly. So opening the IP makes it affordable to poor countries and poor people. — PolitiTweet.org